SZ 342 (Ondansetron Orally Disintegrating 4 mg)
Pill imprint SZ 342 has been identified as Ondansetron hydrochloride (orally disintegrating) 4 mg.
Ondansetron is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting; alcohol dependence; gastroenteritis; nausea/vomiting, postoperative (and more), and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for SZ 342 (Ondansetron Orally Disintegrating 4 mg)
- 4 mg
- Prescription only
- Drug Class:
- 5HT3 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
silicon dioxide colloidal
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|21695-0380||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
- Ondansetron hydrochloride (orally disintegrating) Side Effects
- Ondansetron hydrochloride (orally disintegrating) and Pregnancy
- Ondansetron hydrochloride (orally disintegrating) Drug Interactions
- Support Group Q & A
- 119 Reviews for Ondansetron hydrochloride (orally disintegrating) - Add your own review/rating
Ondansetron hydrochloride (orally disintegrating) is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...